Related Experiment Videos
Catecholamines in experimental spinal cord lesions associated with spinal arachnoiditis
Nihon Seikeigeka Gakkai Zasshi
|December 1, 1984
Summary
Spinal cord arachnoiditis in dogs alters catecholamine levels, particularly noradrenaline. These changes correlate with lesion severity and location, offering insights into neuroinflammation.
Area of Science:
- Neuroscience
- Veterinary Medicine
- Biochemistry
Background:
- Arachnoiditis is an inflammatory condition affecting the spinal cord's arachnoid mater.
- Catecholamines play crucial roles in neurological function and response to injury.
- Understanding neurochemical changes in spinal cord disease is vital for diagnosis and treatment.
Purpose of the Study:
- To investigate the levels of catecholamines, specifically noradrenaline, in the spinal cord and cerebrospinal fluid of dogs with induced arachnoiditis.
- To correlate catecholamine levels with the severity and type of spinal cord lesions.
Main Methods:
- Induction of arachnoiditis in dogs using cisternal kaolin injection.
- Measurement of catecholamines (noradrenaline) in spinal cord gray matter and cerebrospinal fluid using radioenzymatic assay.
- Histopathological examination of spinal cord segments to assess lesion severity and type (degeneration, cavitation).
Main Results:
- Noradrenaline levels in cervical cord gray matter and cerebrospinal fluid peaked in the first week post-induction.
- Thoracic and thoracolumbar cord gray matter noradrenaline levels increased by the 12th week.
- Elevated noradrenaline correlated with degenerative cord lesions, while cavitation was associated with lower levels.
Conclusions:
- Spinal cord arachnoiditis significantly alters noradrenaline levels in a time- and region-dependent manner.
- Noradrenaline levels may serve as a biomarker for spinal cord degeneration in arachnoiditis.
- The findings highlight the complex neurochemical response to inflammatory spinal cord injury.